Opioid-Induced Constipation Treatment Global Market Report 2025

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,490	200 Pages	The Business Research Company	April, 2025	BRC19897059

Best Price Guarantee
Price	from $4,490
Length	200 Pages
Publisher	The Business Research Company
Published Date	April, 2025
SKU	BRC19897059

Opioid-Induced Constipation Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on opioid-induced constipation treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Description:

Where is the largest and fastest growing market for opioid-induced constipation treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The opioid-induced constipation treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Class: Laxatives; Peripherally Acting μ-opioid Receptor Antagonists; Serotonin Receptor Agonists; Prostaglandin

2) By Type: Oral; Parenteral

3) By Distribution Channel: Hospital Pharmacies; Online Pharmacies; Retail Pharmacies

Subsegments:

1) By Laxatives: Osmotic Laxatives; Stimulant Laxatives; Bulk-Forming Laxatives

2) By Peripherally Acting μ-Opioid Receptor Antagonists: Naloxegol; Methylnaltrexone; Alvimopan

3) By Serotonin Receptor Agonists: Prucalopride; Tegaserod

4) By Prostaglandin: Lubiprostone

Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Sanofi S.A.; AstraZeneca plc

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

1. Executive Summary
2. Opioid-Induced Constipation Treatment Market Characteristics
3. Opioid-Induced Constipation Treatment Market Trends And Strategies
4. Opioid-Induced Constipation Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market
5. Global Opioid-Induced Constipation Treatment Growth Analysis And Strategic Analysis Framework: 5.1. Global Opioid-Induced Constipation Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints); 5.2. Analysis Of End Use Industries; 5.3. Global Opioid-Induced Constipation Treatment Market Growth Rate Analysis; 5.4. Global Opioid-Induced Constipation Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion); 5.5. Global Opioid-Induced Constipation Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion); 5.6. Global Opioid-Induced Constipation Treatment Total Addressable Market (TAM)
6. Opioid-Induced Constipation Treatment Market Segmentation: 6.1. Global Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Laxatives; Peripherally Acting Mu-opioid Receptor Antagonists; Serotonin Receptor Agonists; Prostaglandin; 6.2. Global Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Oral; Parenteral; 6.3. Global Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Hospital Pharmacies; Online Pharmacies; Retail Pharmacies; 6.4. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Laxatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Osmotic Laxatives; Stimulant Laxatives; Bulk-Forming Laxatives; 6.5. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Peripherally Acting µ-Opioid Receptor Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Naloxegol; Methylnaltrexone; Alvimopan; 6.6. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Serotonin Receptor Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Prucalopride; Tegaserod; 6.7. Global Opioid-Induced Constipation Treatment Market, Sub-Segmentation Of Prostaglandin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; Lubiprostone
7. Opioid-Induced Constipation Treatment Market Regional And Country Analysis: 7.1. Global Opioid-Induced Constipation Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 7.2. Global Opioid-Induced Constipation Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Opioid-Induced Constipation Treatment Market: 8.1. Asia-Pacific Opioid-Induced Constipation Treatment Market Overview; Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies; 8.2. Asia-Pacific Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.3. Asia-Pacific Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 8.4. Asia-Pacific Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Opioid-Induced Constipation Treatment Market: 9.1. China Opioid-Induced Constipation Treatment Market Overview; 9.2. China Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.3. China Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion; 9.4. China Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Opioid-Induced Constipation Treatment Market: 10.1. India Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.2. India Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 10.3. India Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Opioid-Induced Constipation Treatment Market: 11.1. Japan Opioid-Induced Constipation Treatment Market Overview; 11.2. Japan Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.3. Japan Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 11.4. Japan Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Opioid-Induced Constipation Treatment Market: 12.1. Australia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.2. Australia Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 12.3. Australia Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Opioid-Induced Constipation Treatment Market: 13.1. Indonesia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.2. Indonesia Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 13.3. Indonesia Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Opioid-Induced Constipation Treatment Market: 14.1. South Korea Opioid-Induced Constipation Treatment Market Overview; 14.2. South Korea Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.3. South Korea Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 14.4. South Korea Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Opioid-Induced Constipation Treatment Market: 15.1. Western Europe Opioid-Induced Constipation Treatment Market Overview; 15.2. Western Europe Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.3. Western Europe Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 15.4. Western Europe Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Opioid-Induced Constipation Treatment Market: 16.1. UK Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.2. UK Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 16.3. UK Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Opioid-Induced Constipation Treatment Market: 17.1. Germany Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.2. Germany Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 17.3. Germany Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Opioid-Induced Constipation Treatment Market: 18.1. France Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.2. France Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 18.3. France Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Opioid-Induced Constipation Treatment Market: 19.1. Italy Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.2. Italy Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 19.3. Italy Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Opioid-Induced Constipation Treatment Market: 20.1. Spain Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.2. Spain Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 20.3. Spain Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Opioid-Induced Constipation Treatment Market: 21.1. Eastern Europe Opioid-Induced Constipation Treatment Market Overview; 21.2. Eastern Europe Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.3. Eastern Europe Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 21.4. Eastern Europe Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Opioid-Induced Constipation Treatment Market: 22.1. Russia Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.2. Russia Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 22.3. Russia Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Opioid-Induced Constipation Treatment Market: 23.1. North America Opioid-Induced Constipation Treatment Market Overview; 23.2. North America Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.3. North America Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 23.4. North America Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Opioid-Induced Constipation Treatment Market: 24.1. USA Opioid-Induced Constipation Treatment Market Overview; 24.2. USA Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.3. USA Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 24.4. USA Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Opioid-Induced Constipation Treatment Market: 25.1. Canada Opioid-Induced Constipation Treatment Market Overview; 25.2. Canada Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.3. Canada Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 25.4. Canada Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Opioid-Induced Constipation Treatment Market: 26.1. South America Opioid-Induced Constipation Treatment Market Overview; 26.2. South America Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.3. South America Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 26.4. South America Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Opioid-Induced Constipation Treatment Market: 27.1. Brazil Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.2. Brazil Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 27.3. Brazil Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Opioid-Induced Constipation Treatment Market: 28.1. Middle East Opioid-Induced Constipation Treatment Market Overview; 28.2. Middle East Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.3. Middle East Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 28.4. Middle East Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Opioid-Induced Constipation Treatment Market: 29.1. Africa Opioid-Induced Constipation Treatment Market Overview; 29.2. Africa Opioid-Induced Constipation Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.3. Africa Opioid-Induced Constipation Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion; 29.4. Africa Opioid-Induced Constipation Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Opioid-Induced Constipation Treatment Market Competitive Landscape And Company Profiles: 30.1. Opioid-Induced Constipation Treatment Market Competitive Landscape; 30.2. Opioid-Induced Constipation Treatment Market Company Profiles; 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis; 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis; 30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis; 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
31. Opioid-Induced Constipation Treatment Market Other Major And Innovative Companies: 31.1. Takeda Pharmaceutical Company Limited; 31.2. Daiichi Sankyo Chemical Pharma Co. Ltd.; 31.3. Bausch Health Companies Inc.; 31.4. Boehringer Ingelheim International GmbH.; 31.5. Shionogi & Co. Ltd.; 31.6. Ono Pharmaceutical Co. Ltd.; 31.7. Dr. Reddy's Laboratories Ltd.; 31.8. Hikma Pharmaceuticals plc; 31.9. Mundipharma International Limited; 31.10. Lantheus Holdings Inc.; 31.11. Indivior plc; 31.12. Mallinckrodt Pharmaceuticals; 31.13. Collegium Pharmaceutical Inc.; 31.14. Ironwood Pharmaceuticals Inc.; 31.15. Cosmo Pharmaceuticals SA
32. Global Opioid-Induced Constipation Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Opioid-Induced Constipation Treatment Market
34. Recent Developments In The Opioid-Induced Constipation Treatment Market
35. Opioid-Induced Constipation Treatment Market High Potential Countries, Segments and Strategies: 35.1 Opioid-Induced Constipation Treatment Market In 2029 - Countries Offering Most New Opportunities; 35.2 Opioid-Induced Constipation Treatment Market In 2029 - Segments Offering Most New Opportunities; 35.3 Opioid-Induced Constipation Treatment Market In 2029 - Growth Strategies; 35.3.1 Market Trend Based Strategies; 35.3.2 Competitor Strategies
36. Appendix: 36.1. Abbreviations; 36.2. Currencies; 36.3. Historic And Forecast Inflation Rates; 36.4. Research Inquiries; 36.5. The Business Research Company; 36.6. Copyright And Disclaimer